TVP23B

gene
On this page

Also known as CGI-148YDR084C

Summary

TVP23B (trans-golgi network vesicle protein 23 homolog B, HGNC:20399) is a protein-coding gene on chromosome 17p11.2, encoding Golgi apparatus membrane protein TVP23 homolog B (Q9NYZ1).

Predicted to be involved in protein secretion and vesicle-mediated transport. Predicted to be located in membrane. Predicted to be active in Golgi membrane.

Source: NCBI Gene 51030 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 40 total
  • MANE Select transcript: NM_016078

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20399
Approved symbolTVP23B
Nametrans-golgi network vesicle protein 23 homolog B
Location17p11.2
Locus typegene with protein product
StatusApproved
AliasesCGI-148, YDR084C
Ensembl geneENSG00000171928
Ensembl biotypeprotein_coding
Entrez51030

Gene structure

Transcript identifiers

Ensembl transcripts: 13 — 8 protein_coding, 3 retained_intron, 2 nonsense_mediated_decay

ENST00000307767, ENST00000476139, ENST00000482741, ENST00000571018, ENST00000572845, ENST00000574226, ENST00000574294, ENST00000575261, ENST00000581733, ENST00000582288, ENST00000880247, ENST00000880248, ENST00000920914

RefSeq mRNA: 7 — MANE Select: NM_016078 NM_001316919, NM_001316920, NM_001316921, NM_001316922, NM_001316923, NM_001316924, NM_016078

CCDS: CCDS42274, CCDS82084

Canonical transcript exons

ENST00000307767 — 7 exons

ExonStartEnd
ENSE000026492491878118318781305
ENSE000034617751879757918797668
ENSE000034738391879881218798943
ENSE000034762621880554118806714
ENSE000035450951879089618791040
ENSE000035709751880413818804266
ENSE000036592751878935318789435

Expression profiles

Bgee: expression breadth ubiquitous, 142 present calls, max score 97.85.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.3113 / max 110.5647, expressed in 1510 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
1598192.12661098
1598201.1847831

Top tissues by expression

142 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
islet of LangerhansUBERON:000000697.85gold quality
calcaneal tendonUBERON:000370196.87gold quality
stromal cell of endometriumCL:000225595.38gold quality
adrenal tissueUBERON:001830394.43gold quality
esophagus mucosaUBERON:000246994.41gold quality
pancreasUBERON:000126494.14gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099193.86gold quality
lower esophagus mucosaUBERON:003583493.75gold quality
olfactory segment of nasal mucosaUBERON:000538693.56gold quality
endometriumUBERON:000129593.54gold quality
body of pancreasUBERON:000115093.37gold quality
rectumUBERON:000105293.18gold quality
adenohypophysisUBERON:000219692.77gold quality
gall bladderUBERON:000211092.64gold quality
saliva-secreting glandUBERON:000104492.57gold quality
minor salivary glandUBERON:000183092.50gold quality
duodenumUBERON:000211492.28gold quality
pituitary glandUBERON:000000792.25gold quality
vaginaUBERON:000099692.13gold quality
adrenal glandUBERON:000236992.09gold quality
right adrenal gland cortexUBERON:003582792.07gold quality
left adrenal glandUBERON:000123491.93gold quality
fallopian tubeUBERON:000388991.86gold quality
tonsilUBERON:000237291.81gold quality
right adrenal glandUBERON:000123391.58gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047391.42gold quality
thoracic aortaUBERON:000151591.33gold quality
esophagusUBERON:000104391.29gold quality
ascending aortaUBERON:000149691.28gold quality
left adrenal gland cortexUBERON:003582591.28gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3no0.00

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

93 targeting TVP23B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-340-5P100.0072.504437
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-5692A100.0074.406850
HSA-MIR-5692B100.0071.322622
HSA-MIR-5692C100.0071.322622
HSA-MIR-428299.9975.366408
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-499A-5P99.9870.791323
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-314899.9775.066478
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-590-3P99.9674.346478
HSA-MIR-365899.9673.874379
HSA-MIR-548AT-5P99.9670.832666
HSA-LET-7C-3P99.9573.422862
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AQ-3P99.9372.664867

Literature-anchored findings (GeneRIF, showing 1)

  • The role of FAM18B in regulating retinal microvascular endothelial cell viability, migration, and endothelial tube formation was determined following RNAi-mediated knockdown of FAM18B. (PMID:25221423)

Cross-species orthologs

7 orthologs

OrganismSymbolGene ID
danio_reriozgc:112148ENSDARG00000001804
danio_reriotvp23bENSDARG00000057060
mus_musculusTvp23bENSMUSG00000014177
rattus_norvegicusAABR07006081.1ENSRNOG00000016597
rattus_norvegicusTvp23bENSRNOG00000050649
drosophila_melanogasterCG5021FBGN0035944
caenorhabditis_elegansWBGENE00016400

Paralogs (2): TVP23A (ENSG00000166676), TVP23C (ENSG00000175106)

Protein

Protein identifiers

Golgi apparatus membrane protein TVP23 homolog BQ9NYZ1 (reviewed: Q9NYZ1)

All UniProt accessions (6): Q9NYZ1, E5RIS5, I3L376, J3KS67, J3QL63, K7ENL4

UniProt curated annotations — full annotation on UniProt →

Subcellular location. Membrane.

Similarity. Belongs to the TVP23 family.

RefSeq proteins (7): NP_001303848, NP_001303849, NP_001303850, NP_001303851, NP_001303852, NP_001303853, NP_057162* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR008564TVP23-likeFamily

Pfam: PF05832

UniProt features (9 total): transmembrane region 4, chain 1, region of interest 1, modified residue 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9NYZ1-F180.870.47

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (1): 1

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 136 (showing top): MULLIGHAN_NPM1_SIGNATURE_3_UP, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_SECRETION, MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP, REN_ALVEOLAR_RHABDOMYOSARCOMA_DN, CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN, LINSLEY_MIR16_TARGETS, DELACROIX_RAR_BOUND_ES, FORTSCHEGGER_PHF8_TARGETS_DN, ERBB2_UP.V1_DN, ALKBH3_TARGET_GENES, ARID5B_TARGET_GENES, CIITA_TARGET_GENES, DIDO1_TARGET_GENES

GO Biological Process (2): protein secretion (GO:0009306), vesicle-mediated transport (GO:0016192)

GO Molecular Function (1): protein binding (GO:0005515)

GO Cellular Component (2): Golgi membrane (GO:0000139), membrane (GO:0016020)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
protein transport1
secretion by cell1
establishment of protein localization to extracellular region1
protein localization to extracellular region1
transport1
cellular process1
binding1
Golgi apparatus1
bounding membrane of organelle1
cellular anatomical structure1

Protein interactions and networks

STRING

392 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TVP23BCDRT15Q96T59714
TVP23BTMEM60Q9H2L4687
TVP23BCDRT4Q8N9R6658
TVP23BTEKT3Q9BXF9540
TVP23BTRIM16LQ309B1507
TVP23BTBC1D28Q2M2D7506
TVP23BSMCO2A6NFE2448
TVP23BFBXW10Q5XX13447
TVP23BTMEM87AQ8NBN3429
TVP23BFBXW10BO95170418
TVP23BPIGWQ7Z7B1411
TVP23BTRMT13Q9NUP7394
TVP23BCNIH4Q9P003383
TVP23BHS3ST3B1Q9Y662379
TVP23BMRTFBQ9ULH7370

IntAct

80 interactions, top by confidence:

ABTypeScore
TVP23BTMX2psi-mi:“MI:0915”(physical association)0.560
TVP23BSHISA5psi-mi:“MI:0915”(physical association)0.560
TVP23BSLC35C2psi-mi:“MI:0915”(physical association)0.560
SYT16TVP23Bpsi-mi:“MI:0915”(physical association)0.560
PBX3TVP23Bpsi-mi:“MI:0915”(physical association)0.560
TVP23Bpsi-mi:“MI:0915”(physical association)0.560
YIPF4TVP23Bpsi-mi:“MI:0915”(physical association)0.560
CEP19TVP23Bpsi-mi:“MI:0915”(physical association)0.560
YIPF6TVP23Bpsi-mi:“MI:0915”(physical association)0.560
SLC35C2TVP23Bpsi-mi:“MI:0915”(physical association)0.560
REEP4TVP23Bpsi-mi:“MI:0915”(physical association)0.560
TMEM80TVP23Bpsi-mi:“MI:0915”(physical association)0.560
SLC10A6TVP23Bpsi-mi:“MI:0915”(physical association)0.560
TVP23BYIPF1psi-mi:“MI:0915”(physical association)0.560
SLC10A1TVP23Bpsi-mi:“MI:0915”(physical association)0.560
TMEM14BTVP23Bpsi-mi:“MI:0915”(physical association)0.560
TIMMDC1TVP23Bpsi-mi:“MI:0915”(physical association)0.560
TLCD4TVP23Bpsi-mi:“MI:0915”(physical association)0.560
YIPF2TVP23Bpsi-mi:“MI:0915”(physical association)0.560
SCN3BTVP23Bpsi-mi:“MI:0915”(physical association)0.560
ABHD6TVP23Bpsi-mi:“MI:0915”(physical association)0.560
SHISA5TVP23Bpsi-mi:“MI:0915”(physical association)0.560
HSD17B11TVP23Bpsi-mi:“MI:0915”(physical association)0.560
WLSTVP23Bpsi-mi:“MI:0915”(physical association)0.490

BioGRID (48): TVP23B (Proximity Label-MS), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid), TVP23B (Two-hybrid)

ESM2 similar proteins: A0A8I3S9V6, A0M8U1, A6NH52, E1BWM5, O35089, P13666, P86050, Q00765, Q0VCK9, Q0X0A5, Q1RLU8, Q29S14, Q2PG42, Q3KNM2, Q3ZC24, Q5BJU5, Q5M7T4, Q5R9I4, Q5R9K4, Q5RE33, Q5T4T1, Q5ZJ41, Q5ZJD7, Q6DD32, Q6GM44, Q6NYF1, Q6P360, Q6PI25, Q7TQ48, Q86TD4, Q8C407, Q8L5Y9, Q8MK44, Q8R1Z9, Q91ZQ0, Q940S0, Q96GC9, Q99K70, Q99KU0, Q9BSR8

Diamond homologs: A1CIM7, A1CW41, A2Q9P5, A3LRT4, A4RME3, A5DRE8, A6NH52, A6SFL7, A6ZY50, A7TGB4, A8N1Z1, B0CQN9, B0Y4Q8, B2ALT5, P38962, Q0CSZ7, Q0UV43, Q18449, Q1E9X9, Q29S14, Q2UUK2, Q4WQJ5, Q54LC9, Q5APA2, Q5R9I4, Q6BVH1, Q6C7V5, Q6CTK9, Q6FM91, Q74ZP5, Q7SGB6, Q8IQC1, Q8LEK2, Q96ET8, Q9D8T4, Q9NYZ1, Q9Y7K7, Q86I95, Q8N769

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

40 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance29
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

960 predictions. Top by Δscore:

VariantEffectΔscore
17:18781269:G:GTdonor_gain1.0000
17:18789350:CAG:Cacceptor_loss1.0000
17:18789351:A:AGacceptor_gain1.0000
17:18789351:AG:Aacceptor_gain1.0000
17:18789352:G:GGacceptor_gain1.0000
17:18789352:GG:Gacceptor_gain1.0000
17:18789352:GGAT:Gacceptor_gain1.0000
17:18789352:GGATA:Gacceptor_gain1.0000
17:18789432:TCAG:Tdonor_loss1.0000
17:18789433:CAGG:Cdonor_loss1.0000
17:18789434:AG:Adonor_loss1.0000
17:18789435:GG:Gdonor_loss1.0000
17:18789436:GTAG:Gdonor_loss1.0000
17:18789437:T:Gdonor_loss1.0000
17:18790886:T:TAacceptor_gain1.0000
17:18797577:AGAAT:Aacceptor_gain1.0000
17:18797578:GA:Gacceptor_gain1.0000
17:18797578:GAAT:Gacceptor_gain1.0000
17:18797578:GAATG:Gacceptor_gain1.0000
17:18797665:AAAGG:Adonor_loss1.0000
17:18797666:AAGG:Adonor_loss1.0000
17:18797667:AG:Adonor_loss1.0000
17:18797668:GGTAA:Gdonor_loss1.0000
17:18797669:G:GAdonor_loss1.0000
17:18797670:T:Adonor_loss1.0000
17:18798806:TTATA:Tacceptor_loss1.0000
17:18798807:TATA:Tacceptor_loss1.0000
17:18798809:TA:Tacceptor_loss1.0000
17:18798810:A:Gacceptor_loss1.0000
17:18798811:GGA:Gacceptor_gain1.0000

AlphaMissense

1355 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
17:18791040:G:CK80N0.989
17:18791040:G:TK80N0.989
17:18798860:T:CF127L0.986
17:18798862:T:AF127L0.986
17:18798862:T:GF127L0.986
17:18797612:T:AW92R0.984
17:18797612:T:CW92R0.984
17:18797654:T:CF106L0.981
17:18797656:T:AF106L0.981
17:18797656:T:GF106L0.981
17:18791026:T:CF76L0.979
17:18791028:T:AF76L0.979
17:18791028:T:GF76L0.979
17:18791024:A:TD75V0.972
17:18797581:T:AN81K0.972
17:18797581:T:GN81K0.972
17:18798893:T:AW138R0.972
17:18798893:T:CW138R0.972
17:18790936:A:CS46R0.970
17:18790938:T:AS46R0.970
17:18790938:T:GS46R0.970
17:18791024:A:CD75A0.969
17:18797589:G:AG84D0.963
17:18804153:G:CG160R0.962
17:18791020:T:CC74R0.960
17:18791039:A:TK80M0.959
17:18791025:C:AD75E0.958
17:18791025:C:GD75E0.958
17:18797607:T:CL90P0.958
17:18797614:G:CW92C0.958

dbSNP variants (sampled 300 via entrez): RS1000226487 (17:18801334 G>T), RS1000587913 (17:18788288 G>A), RS1000618941 (17:18788054 T>A,C), RS1000768770 (17:18794287 T>C), RS1001138923 (17:18794720 T>A), RS1001404611 (17:18782485 A>G), RS1001416826 (17:18788944 A>G), RS1001429076 (17:18789149 TC>T), RS1001487527 (17:18781973 G>T), RS1001767274 (17:18782947 A>G), RS1001941231 (17:18793998 AAG>A), RS1001972427 (17:18793756 T>C,G), RS1002323452 (17:18781406 C>T), RS1002354226 (17:18781213 C>G), RS1002465670 (17:18806145 T>C)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

27 total (human), top 27 by PubMed support.

ChemicalActions (top 5)PubMed papers
Air Pollutantsaffects cotreatment, increases abundance, increases oxidation, decreases expression, increases expression3
sodium arsenitedecreases expression, increases expression2
Tobacco Smoke Pollutionincreases expression2
Cadmium Chlorideincreases abundance, increases expression2
Particulate Matterincreases abundance, increases expression, decreases expression2
aristolochic acid Idecreases expression1
dicrotophosdecreases expression1
alpha-pineneaffects cotreatment, increases oxidation, increases abundance1
hydroxyhydroquinoneincreases expression1
methacrylaldehydeaffects cotreatment, increases oxidation, increases abundance1
di-n-butylphosphoric acidaffects expression1
perfluorooctane sulfonic aciddecreases expression1
CGP 52608affects binding, increases reaction1
jinfukangdecreases expression1
bisphenol AFincreases expression1
Sunitinibincreases expression1
Acroleinaffects cotreatment, increases oxidation, increases abundance1
Benzo(a)pyrenedecreases methylation1
Cadmiumincreases abundance, increases expression1
Oxygendecreases expression1
Ozoneaffects cotreatment, increases oxidation, increases abundance1
Thiramincreases expression1
Tretinoinincreases expression1
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxidedecreases expression1
Asbestos, Crocidoliteincreases expression1
Copper Sulfatedecreases expression1
Volatile Organic Compoundsaffects cotreatment, increases oxidation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.